Literature DB >> 2076720

Effects of cimetropium bromide on gallbladder contraction in response to oral and intraduodenal olive oil.

L Marzio1, F Di Felice, V Celiberti, O Pieramico, L Grossi, M DiGioacchino, B P Imbimbo, F Cuccurullo.   

Abstract

To evaluate the influence of the stomach and the cholinergic system on gallbladder contraction induced by physiological stimuli, the reduction in gallbladder volume in 7 healthy volunteers has been studied by real-time ultrasonography after the oral and intraduodenal administration of olive oil, preceded by pretreatment with cimetropium bromide or placebo. After an overnight fast, each subject swallowed 50 ml olive oil or it was administered through a naso-duodenal tube in the proximal duodenum. Cimetropium bromide 5 mg or placebo was given intravenously under double-blind control. After the placebo pretreatment, gallbladder contraction was greater and faster after intraduodenal oil than after oral oil. Cimetropium bromide decreased the extent, velocity and duration of gallbladder contraction induced by intraduodenal olive oil but it only reduced the velocity of the contraction induced by oil given orally. It is concluded that in normal human subjects the stomach modulates the extent and velocity of postprandial gallbladder contraction and that anticholinergic agents antagonize the gastric and duodenal phases of the response of the gallbladder to a meal.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2076720     DOI: 10.1007/BF00315412

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  24 in total

1.  Data normalization before statistical analysis: keeping the horse before the cart.

Authors:  A A Hancock; E N Bush; D Stanisic; J J Kyncl; C T Lin
Journal:  Trends Pharmacol Sci       Date:  1988-01       Impact factor: 14.819

2.  Gallbladder emptying in duodenal ulcer patients having undergone Billroth II gastrectomy.

Authors:  L Marzio; F Di Felice; V Celiberti; M Di Gioacchino; A Mezzetti; F Cuccurullo; P Innocenti
Journal:  Digestion       Date:  1988       Impact factor: 3.216

3.  A critical evaluation of real-time ultrasonography for the study of gallbladder volume and contraction.

Authors:  G T Everson; D Z Braverman; M L Johnson; F Kern
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

4.  Effect of cholinergic agonists and antagonists on gallbladder volume in fasting man.

Authors:  L Marzio; F Capone; M Neri; F di Felice; V Celiberti; A Mezzetti; D Giorgi; F Cuccurullo
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

5.  Inhibition of caerulein-induced gall bladder emptying by cimetropium bromide in humans.

Authors:  L Gullo; C Scarpignato; P Casanova; E Corcioni; L Zappia; B P Imbimbo
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

6.  Inhibitory effect of atropine on cholecystokinin-induced gallbladder contraction in man.

Authors:  L Gullo; L Bolondi; P Priori; P Casanova; G Labò
Journal:  Digestion       Date:  1984       Impact factor: 3.216

7.  Release of cholecystokinin in man: correlation of blood levels with gallbladder contraction.

Authors:  I Wiener; K Inoue; C J Fagan; P Lilja; L C Watson; J C Thompson
Journal:  Ann Surg       Date:  1981-09       Impact factor: 12.969

8.  Gallbladder kinetics in obese patients. Effect of a regular meal and low-calorie meal.

Authors:  L Marzio; F Capone; M Neri; A Mezzetti; C De Angelis; F Cuccurullo
Journal:  Dig Dis Sci       Date:  1988-01       Impact factor: 3.199

9.  Cimetropium bromide: in vitro and in vivo evaluation of spasmolytic activity on human and dog colon.

Authors:  A Sagrada; A Schiavone; A Cefalà; R Micheletti
Journal:  Digestion       Date:  1989       Impact factor: 3.216

10.  Atropine antagonizes cholecystokinin and cerulein-induced gallbladder evacuation in man: a real-time ultrasonographic study.

Authors:  L Marzio; A M Di Giammarco; M Neri; F Cuccurullo; P Malfertheiner
Journal:  Am J Gastroenterol       Date:  1985-01       Impact factor: 10.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.